Company profile

Aibo Medical Robot

Aibo Medical Robot, also branded Abrobo, develops robotic systems for vascular intervention. The Shenzhen company integrates catheter manipulation, imaging...

Facts

Segment: SURGICAL
Country: China
Headquarters: Shenzhen
Website: https://www.abrobo.com/

About Aibo Medical Robot

Abrobo’s vascular-intervention systems place the physician’s controls apart from the patient-side instrument mechanism. The operator directs catheter and guidewire movement from a console, supporting work away from the immediate X-ray field. The PANVIS-A platform uses fingertip catheter controls and can move instruments independently or synchronise their movement after sheath placement.

The company is developing a family of systems for coronary, neurovascular and broader vascular procedures. For PANVIS-A, it has announced a multicentre real-world study led by Guangdong Provincial People’s Hospital and Zhujiang Hospital of Southern Medical University. This programme evaluates the system in clinical workflows while retaining physician control of the intervention.

Market context

PRODUCTION

Summary

Type: Interventional medical robotics company

Core: Vascular intervention robots

Function: Surgical assistance

Audience: Healthcare providers

Recent verified events

Aibo Medical Robot raises RMB 100 million Series A — 2023-06-01